Antiva Biosciences, Inc. — Form D

Antiva Biosciences, Inc. of Redwood City, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-19. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (41)

Showing 25 of 41 people.

NameRoleLocation
Michael D CannonDirectorEmeryville, CA
Wende S HuttonDirectorSouth San Francisco, CA
Steven P JamesDirectorSouth San Francisco, CA
Ting P JiaDirectorSouth San Francisco, CA
David P Kabakoff, Ph.D.DirectorSouth San Francisco, CA
Vinzenz P PloererDirectorCambridge, MA
Benjamin P RovinskiDirectorSouth San Francisco, CA
Oranee D DanielsExecutive OfficerSouth San Francisco, CA
Raju D Gadiraju, Ph.D.Executive OfficerSouth San Francisco, CA
Sarah P WalterExecutive OfficerSouth San Francisco, CA
David P KabakoffDirectorBeltsville, MD
Steven JamesDirectorREDWOOD CITY, CA
Clifford SamuelDirectorRedwood City, CA
Beni RovinskiDirectorRedwood City, CA
Florencia SegalDirectorRedwood City, CA
Gail MaderisDirectorRedwood City, CA
Gail MaderisExecutive OfficerRedwood City, CA
Kristine BallDirectorRedwood City, CA
Kristine BallExecutive OfficerRedwood City, CA
Elaine ChienExecutive OfficerRedwood City, CA
Brian GoodmanDirectorRedwood City, CA
Wende HuttonDirectorMenlo Park, CA
Sarah WalterExecutive OfficerRedwood City, CA
Raju GadirajuExecutive OfficerRedwood City, CA
Michael CannonDirectorEmeryville, CA

Other filings by this issuer (10)

FiledFormOfferingSold
2024-10-11D/A$53.0M$38.5M
2023-05-05D$53.0M$26.6M
2021-11-03D$31.0M$15.6M
2017-08-28D/A$25.9M$14.7M
2017-04-05D$22.3M$11.1M
2015-06-11D$16.0M$8.9M
2014-12-23D$2.5M$1.7M
2014-07-10D$1.3M$1.1M
2013-09-05D/A$1.1M$1.1M
2013-03-06D$1.0M$501K

More